KYMR - Company ID 0001815442
As of 2026-09-08, Kymera Therapeutics, Inc. (KYMR) has a market capitalization of $9.66 B, making it the #983 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-08 | $9.66 B |
| 2026-09-07 | $9.66 B |
| 2026-09-06 | $9.66 B |
| 2026-09-05 | $9.66 B |
| 2026-09-04 | $9.66 B |
| 2026-09-03 | $9.65 B |
| 2026-09-02 | $9.76 B |
| 2026-09-01 | $9.79 B |
| 2026-08-31 | $9.69 B |
| 2026-08-30 | $9.72 B |
| 2026-08-29 | $9.72 B |
| 2026-08-28 | $9.74 B |
As of 2026-09-08, Kymera Therapeutics, Inc. (KYMR) has a market capitalization of $9.66 B, making it the #983 most valuable US-listed company.
Kymera Therapeutics, Inc. is the #983 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-27 | $9.89 B |
| 2026-08-26 | $10.33 B |
| 2026-08-25 | $10.09 B |
| 2026-08-24 | $9.96 B |
| 2026-08-23 | $9.85 B |
| 2026-08-22 | $9.85 B |
| 2026-08-21 | $9.85 B |
| 2026-08-20 | $10.10 B |
| 2026-08-19 | $10.47 B |
| 2026-08-18 | $9.98 B |
| 2026-08-17 | $9.99 B |
| 2026-08-16 | $9.66 B |
| 2026-08-15 | $9.66 B |
| 2026-08-14 | $9.61 B |
| 2026-08-13 | $9.41 B |
| 2026-08-12 | $9.38 B |
| 2026-08-11 | $9.02 B |
| 2026-08-10 | $8.89 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.